57 related articles for article (PubMed ID: 33881615)
21. Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity.
Amin M; Trikalinos N; Chatterjee D
Hum Pathol; 2021 Aug; 114():36-43. PubMed ID: 33891968
[TBL] [Abstract][Full Text] [Related]
22. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Bal M; Sharma A; Rane SU; Mittal N; Chaukar D; Prabhash K; Patil A
Head Neck Pathol; 2022 Jun; 16(2):375-387. PubMed ID: 34401980
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine neoplasm update: toward universal nomenclature.
Rindi G; Inzani F
Endocr Relat Cancer; 2020 Jun; 27(6):R211-R218. PubMed ID: 32276263
[TBL] [Abstract][Full Text] [Related]
25. Cloacogenic Adenocarcinoma of the Vulva: A Case Report and Review of the Literature.
Tepeoğlu M; Üner H; Haberal AN; Özen Ö; Kuşçu E
Turk Patoloji Derg; 2018; 34(3):255-258. PubMed ID: 28272666
[TBL] [Abstract][Full Text] [Related]
26. Primary small cell carcinoma of the vagina.
Oliveira R; Bócoli MC; Saldanha JC; Murta EF; Nomelini RS
Case Rep Obstet Gynecol; 2013; 2013():827037. PubMed ID: 23878751
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine tumors of the genital tract.
Eichhorn JH; Young RH
Am J Clin Pathol; 2001 Jun; 115 Suppl():S94-112. PubMed ID: 11993694
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine tumor (NET) of the vagina in the light of WHO 2020 2-tiered grading system: clinicopathological report of the first described case.
Inzani F; Santoro A; Angelico G; Mastrosimini MG; Masciullo V; Salutari V; Zannoni GF
Virchows Arch; 2022 Mar; 480(3):687-691. PubMed ID: 33881615
[TBL] [Abstract][Full Text] [Related]
29. Cyto-histology in NET: what is necessary today and what is the future?
Inzani F; Petrone G; Fadda G; Rindi G
Rev Endocr Metab Disord; 2017 Dec; 18(4):381-391. PubMed ID: 28871510
[TBL] [Abstract][Full Text] [Related]
30. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.
Mete O; Wenig BM
Head Neck Pathol; 2022 Mar; 16(1):123-142. PubMed ID: 35312985
[TBL] [Abstract][Full Text] [Related]
31. [Grading of neuroendocrine tumors].
Saeger W; Schnabel PA; Komminoth P
Pathologe; 2016 Jul; 37(4):304-13. PubMed ID: 27379621
[TBL] [Abstract][Full Text] [Related]
32. Pathology: Classification and Immunoprofile.
Blank A; Schmitt A; Perren A
Front Horm Res; 2015; 44():104-14. PubMed ID: 26303707
[TBL] [Abstract][Full Text] [Related]
33. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G; La Rosa S
Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440
[TBL] [Abstract][Full Text] [Related]
34. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
[TBL] [Abstract][Full Text] [Related]
35. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.
La Rosa S
Endocr Pathol; 2023 Mar; 34(1):79-97. PubMed ID: 36797453
[TBL] [Abstract][Full Text] [Related]
37. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
[TBL] [Abstract][Full Text] [Related]
38. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
39. [Gastroenteropancreatic neuroendocrine neoplasms: concepts and related issues].
Lai M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):5-9, 23. PubMed ID: 27045235
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.
Waseem N; Aparici CM; Kunz PL
J Nucl Med; 2019 Jul; 60(7):882-891. PubMed ID: 30850504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
